Suriname vs Turkmenistan: Reported paralytic polio cases per million
Suriname
0 cases per million
in 2000
Turkmenistan
0 cases per million
in 2023
Suriname rank
26th
Turkmenistan rank
26th
Reported paralytic polio cases per million over time
- Suriname
- Turkmenistan
How they compare
Suriname currently reports 0 cases per million against 0 cases per million in Turkmenistan, a difference of 0 cases per million.
Across all 10 years both countries report, Turkmenistan has been ahead every year.
Suriname ranks 26th and Turkmenistan ranks 26th of 199 countries.
Turkmenistan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Suriname | Turkmenistan | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 cases per million | 1.06 cases per million | 1.06 cases per million | Turkmenistan |
| 2000s | 0 cases per million | 0 cases per million | 0 cases per million | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher reported paralytic polio cases per million, Suriname or Turkmenistan?
- Suriname, at 0 cases per million against 0 cases per million in Turkmenistan as of 2000.
- What is the difference in reported paralytic polio cases per million between Suriname and Turkmenistan?
- 0 cases per million, with Suriname ahead.
- How many years of comparable data are there for Suriname and Turkmenistan?
- 10 years are reported by both, from 1991 to 2000.
- How do Suriname and Turkmenistan rank globally for reported paralytic polio cases per million?
- Suriname ranks 26th and Turkmenistan ranks 26th of 199 countries.
- Where does this data come from?
- World Health Organization (2019); World Health Organization (2024); Population based on various sources (2023) – with major processing by Our World in Data, published as Reported paralytic polio cases per million. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Sum of wild poliovirus cases and circulating vaccine derived poliovirus cases per million people.